Cargando…
Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism
BACKGROUND: Chemotherapy can induce premature ovarian insufficiency (POI) and reduce fertility in young female patients. Currently, there is no effective therapy for POI. Human amnion-derived mesenchymal stem cells (hAD-MSCs) may be a promising seed cell for regenerative medicine. This study investi...
Autores principales: | Ling, Li, Feng, Xiushan, Wei, Tianqin, Wang, Yan, Wang, Yaping, Wang, Ziling, Tang, Dongyuan, Luo, Yanjing, Xiong, Zhengai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347748/ https://www.ncbi.nlm.nih.gov/pubmed/30683144 http://dx.doi.org/10.1186/s13287-019-1136-x |
Ejemplares similares
-
Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats
por: Ling, Li, et al.
Publicado: (2017) -
POI: Premature Ovarian Insufficiency/Pregnancy or Infertility?
por: Soave, Ilaria, et al.
Publicado: (2013) -
Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI)
por: Ling, Li, et al.
Publicado: (2022) -
Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI)
por: Ishizuka, Bunpei
Publicado: (2021) -
Stem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency
por: Polonio, Alba M., et al.
Publicado: (2021)